Table 2 Outcomes of most recent transplant in patients treated with eculizumab prophylaxis pre-transplant versus patients not treated with eculizumab prophylaxis pre-transplant
Variable | Eculizumab prophylaxis (10 patients) | No eculizumab prophylaxis (9 patients) | p-value |
|---|---|---|---|
Follow-up post-transplant, median years (range) | 3.48 (0.36–7.21) | 3.80 (1.30–14.70) | 0.33 |
aHUS recurrence | 0 (0%) | 2 (22%) | 0.15 |
Graft outcome | |||
Median creatinine, mg/dL (range) | 1.3 (0.9–2.0) | 1.1 (0.7 to 2.1) | 0.46 |
Median eGFR, ml/min/m2 (range) | 55 (43–76) | 61 (32–92) | 0.55 |
Hemodialysis, (n) | 1 (10%) | 4 (44%) | 0.09 |
Death, (n) | 0 (0%) | 0 (0%) | – |